Phase II study of high-dose 4'-epidoxorubicin in the treatment of advanced gastrointestinal cancer.
Vorobiof
D A
DA
Department of Medical Oncology, University of Pretoria, Republic of South Africa.
Falkson
G
G
D000328:Adult; D000368:Aged; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy*
D015251:Epirubicin